TOP TEN perturbations for 394_at (Homo sapiens)
Organism: Homo sapiens
Gene: 394_at
Selected probe(set): 202179_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array
Expression of 394_at (202179_at) across 6674 perturbations tested by GENEVESTIGATOR:
Hep-G2 / HepaRG
Relative Expression (log2-ratio):3.5301752Number of Samples:9 / 12
Experimental | Hep-G2 |
Human primary cancer cell line derived from the liver of a patient with hepatocellular carcinoma. Synonyms:HEP-G2; Hep G2; HEP G2; HepG2; HEPG2 Cellosaurus code: | |
Control | HepaRG |
Immortalized cancer cell line derived from female patient with hepatocellular carcinoma. Cells can be induced to differentiate into hepatocyte-like cells by exposure to DMSO. Synonyms:Hepa-RG Cellosaurus code: |
hepatocyte (ESC) / HepaRG
Relative Expression (log2-ratio):3.4797153Number of Samples:8 / 12
Experimental | hepatocyte (ESC) |
Hepatocyte-like cells differentiated from embryonic stem cells (ESC) | |
Control | HepaRG |
Immortalized cancer cell line derived from female patient with hepatocellular carcinoma. Cells can be induced to differentiate into hepatocyte-like cells by exposure to DMSO. Synonyms:Hepa-RG Cellosaurus code: |
engineered skin substitute study 2 (intermediate) / engineered skin substitute study 1 (intermediate)
Relative Expression (log2-ratio):3.3466053Number of Samples:6 / 3
Experimental | engineered skin substitute study 2 (intermediate) |
Human skin substitutes tissue samples collected after 14 and 28 days after transplantation to athymic mice. | |
Control | engineered skin substitute study 1 (intermediate) |
Human skin substitutes tissue samples collected after 7 days in culture. |
wound healing study 2 (ex vivo; DMSO) / normal skin tissue (ex vivo)
Relative Expression (log2-ratio):-3.3292341Number of Samples:3 / 3
Experimental | wound healing study 2 (ex vivo; DMSO) |
Ex vivo skin samples obtained from healthy donors following reduction surgery of abdomen, and incubated in culture medium containing DMSO for 4 days. To make sure that mainly epidermis was present in the samples, as much dermal tissue as possible was removed by dissection. Skin was sliced into 1x10 mm slices and incubated in keratinocyte medium for four days with 1:1000 fold dilution of DMSO. The cultivation was performed in serum-free keratinocyte medium supplemented with transferrin, hEGF (0.15 ng/mL), 0.5 mg/mL hydrocortisone, gentamicin, amphotericin B, and epinephrine but without insulin. | |
Control | normal skin tissue (ex vivo) |
Normal skin samples obtained from healthy donors following reduction surgery of abdomen. To make sure that mainly epidermis was present in the samples, as much dermal tissue as possible was removed by dissection. |
Langerhans cell histiocytosis study 2 (multisystem) / normal epidermal Langerhans cell sample
Relative Expression (log2-ratio):-3.3052006Number of Samples:2 / 10
Experimental | Langerhans cell histiocytosis study 2 (multisystem) |
Langerhans cell histiocytes (LCH, CD207+) samples isolated from LCH lesions of patients with multifocal, multisystem (disseminated) disease. Both patients received chemotherapy. Sites of LCH lesions: subj.ID:1 (skin, lungs, multiple skull, mastoid, gingiva), subj.ID:13 (mandible, skull, vertebrae, recurrent orbit, liver, spleen, pituitary gland). | |
Control | normal epidermal Langerhans cell sample |
Normal epidermal Langerhans cells (CD207+) were isolated from skin of children donors (age < 18 years). The Langerhans cells were isolated from presumably healthy tissue. |
NCI-H358 / HCC827
Relative Expression (log2-ratio):-3.0482445Number of Samples:6 / 6
Experimental | NCI-H358 |
Human bronchioloalveolar carcinoma derived cell line. Synonyms:H358; H-358 Cellosaurus code: | |
Control | HCC827 |
Human primary cancer cell line derived from the lung of a patient with non-small-cell lung cancer. Synonyms:HCC-827; HCC0827 Cellosaurus code: |
Langerhans cell histiocytosis study 2 (unifocal) / normal epidermal Langerhans cell sample
Relative Expression (log2-ratio):-2.9338398Number of Samples:8 / 10
Experimental | Langerhans cell histiocytosis study 2 (unifocal) |
Langerhans cell histiocytes (LCH, CD207+) samples isolated from LCH lesions of patients with unifocal, single system disease (bone lesion). | |
Control | normal epidermal Langerhans cell sample |
Normal epidermal Langerhans cells (CD207+) were isolated from skin of children donors (age < 18 years). The Langerhans cells were isolated from presumably healthy tissue. |
melanoma study 34 (metastatic) / melanoma study 34 (in situ)
Relative Expression (log2-ratio):-2.8848333Number of Samples:40 / 2
Experimental | melanoma study 34 (metastatic) |
Metastatic tumor tissue sample obtained from the patients with metastatic malignant melanoma of the skin. Metastatic samples composed of 22 macroscopic lymph node metastases, 16 subcutaneous metastases and 2 solid organ metastases (adrenal and brain). | |
Control | melanoma study 34 (in situ) |
Tumor tissue from the skin of patients with melanoma in situ. |
engineered skin substitute study 2 (late) / engineered skin substitute study 2 (early)
Relative Expression (log2-ratio):2.8822556Number of Samples:5 / 6
Experimental | engineered skin substitute study 2 (late) |
Human skin substitutes tissue samples collected after 42 and 56 days after transplantation to athymic mice. | |
Control | engineered skin substitute study 2 (early) |
Human skin substitutes tissue samples collected after 3 and 7 days after transplantation to athymic mice. |
engineered skin substitute study 2 (late) / engineered skin substitute study 1 (late)
Relative Expression (log2-ratio):2.8486013Number of Samples:5 / 3
Experimental | engineered skin substitute study 2 (late) |
Human skin substitutes tissue samples collected after 42 and 56 days after transplantation to athymic mice. | |
Control | engineered skin substitute study 1 (late) |
Human skin substitutes tissue samples collected after 14 days in culture. |